Latest news
New study identifies 87 genes linked to AMD
Posted: Friday 26 April 2024
Researchers at the National Eye Institute in the USA have discovered 87 genes in retinal cells that could be affected by environmental factors which may influence the risk of developing age-related macular degeneration (AMD).
Find out more
Macular Society partners with UK’s largest health research programme
Posted: Friday 5 April 2024
The Macular Society is proud to announce a new partnership with Our Future Health, a groundbreaking initiative aimed at revolutionising research into health conditions such as age-related macular degeneration (AMD).
Find out more
Home monitoring for patients with AMD
Posted: Wednesday 3 April 2024
Health tech startup OKKO Health has shared new insights from its UK research study on home monitoring for age-related macular degeneration (AMD). The study is being carried out in collaboration with the Macular Society.
Find out more
‘Regular injections essential in maintaining vision’
Posted: Wednesday 27 March 2024
Early diagnosis, prompt initial treatment, and regular injections help stabilise vision in most eyes with wet age-related macular degeneration (AMD), according to a new report published by the Royal College of Ophthalmologists
Find out more
All you need to know about implantable magnifying lenses for macular disease
Posted: Monday 25 March 2024
Intraocular lenses (IOLs) were the focus of our My Macular and Me webinar in March, as Dr Julie Silvestri shed light on the potential of these devices, which aim to improve vision for people living with sight loss.
Find out more
Encouraging results from light therapy study for dry AMD
Posted: Friday 1 March 2024
Early results from a study assessing the effectiveness of the Valeda Light Delivery System for treating dry age-related macular degeneration (AMD), have shown promise.
Find out more
Increased dose of Eylea to extend treatment intervals
Posted: Friday 1 March 2024
Renowned retinal specialist Dr Kenneth Fan has called the higher approved dose of Eylea for patients with wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO), “a pivotal moment” for the treatment of these conditions.
Find out more
Patients reveal communication gaps in diagnosis
Posted: Monday 5 February 2024
Patients have highlighted noticeable gaps in communication when they are first diagnosed with macular disease, or if they are considered at risk of developing the condition.
Find out more
Another new drug offers hope for Stargardt patients
Posted: Monday 29 January 2024
Another drug to potentially treat Stargardt has shown positive results in slowing down the progression of the disease in a recent trial.
Find out more
‘We’re hoping our research can lead to potential treatments’
Posted: Wednesday 20 December 2023
A groundbreaking research project is underway, focusing on screening a library of already licensed drugs to potentially treat Stargardt disease.
Find out more
World Geographic Atrophy Day raises awareness of common condition
Posted: Tuesday 5 December 2023
The first-ever World Geographic Atrophy Day raises awareness of the condition and the five million people living with it across the globe.
Find out more
Macular disease under the spotlight at Conservative conference
Posted: Wednesday 25 October 2023
The Macular Society's director of research took to the stage at the Conservative Party Conference earlier this month to shine a light on the need to improve healthcare, especially for people living with macular disease.
Find out more
Get the latest news and advice from the Macular Society
To hear about life-changing research, treatments and tips for living with sight loss, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter